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The chromatographic separation of the n-hexane extract from the stem bark of Walsura 
pinnata Hassk (Meliaceae) which was collected at Kuala Lipis, Pahang, led to the 
isolation of nine chemical constituents. Their structures were characterized to be ledol 
(115), oplopanone (116), betulonic acid (117), oleanonic acid (118), 3-oxoolean-11-en-
13β(28)-olide (119), 12α-hydroxy-3-oxooleanano-28,13-lactone (120), 3-oxoursolic 
acid (121), 3-ketours-11-en-13β(28)-olide (122), 3β-hydroxy-5-glutinen-28-oic acid 
(123). The structural elucidation of these compounds was determined by spectroscopic 
data interpretation. Betulonic acid (117) and 3β-hydroxy-5-glutinen-28-oic acid (123) 
were found to be cytotoxic against a series of human cancer cell lines with an IC50 = 19 
















Pemisahan kromatografi ekstrak heksana daripada kulit pokok Walsura pinnata Hassk 
(Meliaceae) yang diperoleh dari, Kuala Lipis, Pahang telah menghasilkan sembilan 
sebatian kimia. Strukturnya telah dikenalpasti sebagai ledol (115), oplopanon (116), 
asid betulonik (117), asid oleanonik (118), 3-oksoolean-11-en-13β (28)-olid (119), 12α-
hidroksi-3-oksooleanan-28,13-lakton (120), asid 3-oksoursolik (121), 3-ketours-11-en-
13β (28)-olid (122), asid 3β-hidroksi-5-glutinen-28-oik (123). Penentuan struktur 
sebatian organik ini adalah melalui kaedah spektroskopi. Asid betulonik (117) dan asid 
3β-hidroksi-5-glutinen-28-oik (123) didapati mempunyai aktiviti sitotoksik terhadap 
beberapa sel kanser manusia dengan nilai kepekatan 50 peratus perencatan (IC50) 
masing - masing  adalah = 19 µM, 18 µM pada sel HepG2; 12 µM, 25 µM ke atas sel 
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World Health Organisation (WHO) has defined medicinal plants as plants that 
contain some organic compounds or properties which produce definite pharmacological 
action on the human body that can be used for therapeutic purposes (WHO 2008) and 
these bioactive substances include tannins, alkaloids, carbohydrates, terpenoids, steroids 
and flavonoids
1,2
. Medicinal plants have great and important roles as mediator of 
ecological interactions; but in most cases, the substances appear to serve no useful 
purpose in the microorganisms producing it
2,3
.  
Natural products have served as the source and inspiration for a large fraction of the 
current pharmaceuticals. Although estimates is very dependent on the definition of what 
is considered a natural product derived drug, it is safe to say that between 25% and 50% 
of currently marketed drugs owe their origin to natural products
4
. In addition to their 
direct use as drugs, many natural products have served as lead compounds for medicinal 
chemistry. In the case of anticancer and anti-infective agents the proportion is even 
higher, and the estimate is that almost two-thirds of such agents are derived from natural 
products
5
. In anticancer area the lead compound podophyllotoxin led to the clinical 
drugs etoposide 1 and teniposide 2, and the lead compound camptothecin 3 spawned the 



























































The use of plants as the cure of many ailments by the local people have been well 
documented as early as 1935
7
. Medicinal plants were also available at that time in the 
markets or sidewalks, mostly in crude form, sold by traditional medicine practitioners. It 
was not until the 1950s that any attempt was made to carry out scientific investigation 
on these medicinal plants although awareness on the usefulness of such plants has been 
established for quite some time. Research at that time was simple and straightforward 
but effective which involved surveys of plant species available in a certain designated 
area, their ethno botanical use, and laboratory testing for certain classes of compounds 
which were already known to be effective drugs. So it was not surprising then that most 
of the phytochemical surveys carried out concentrated on the testing of alkaloids in 
these plants since alkaloids were already proven to be effective as drugs. 
A drug takes several years and millions of dollars to be developed, hence making 
the process very capital-intensive, the risks are also high and the success rate is not very 
good. Despite all these, natural products drug discovery programmes are still in 
existence all over the world, mainly because of the high chemical diversity from natural 
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products as compared to synthetics, and the potential of these natural products is largely 
known. Moreover, the large number of terrestrial and marine species yet uninvestigated, 
and the back to nature trend. In addition, the modern technology and the advancements 
in this field have made natural products drug discovery programmes attractive. Thus 
high throughput screens and sensitive instrumentation for example (LCMS, X-ray 
crystallography, HPLC etc) for structure elucidation has reduced significantly the 
amount of time (and also the amount of sample) required for the first stage of the 
investigation.  
In Malaysia, 2000 species from 14500 flowering plants have been reported to 
contain medicinal properties and many have been scientifically proven
8
. Malaysia is 
wealthy in her plant diversity and potential lead compounds and therapeutics are still 
waiting to be explored. The huge diversity of the Malaysian flora means that we can 
expect well diversed chemical structures from their secondary metabolites, and 
chemical diversity is one of the plus factors that makes natural products excellent 
candidates for any screening programme. Plant derived compounds offer potential 





The Meliaceae is a medium-sized family of woody plants growing in the tropics and 
subtropics, comprising 51 genera and about 575 species of trees and rare shrubs. Most 
members of the family have large leaves, with the leaflets arranged in the form of a 
feather, and branched flower clusters. The fruit is fleshy and coloured or a leathery 
capsule. This family is extremely useful to man for the high quality timbers and ease 
with which some species can be grown in plantation
10
. Generic monograph of the 
Meliaceae, divided Meliaceae into four subfamilies as shown in Figure 1.2a and 1.2b. 
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 Figure 1.2a : Classification of Meliaceae Family 
 
Figure 1.2b : Genus from Trichilieae tribe. 
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1.3 THE CHEMISTRY OF MELIACEAE 
The Meliaceae produce wide range of compounds, flavonoids, chromones, 
coumarins, benzofurans, mono-, sesqui-, di- and triterpenoids, but are best known for 
the production of limonoids which are tetranortriterpenoids with β-substitued furanyl 
ring at C17α. Alkaloids are rarely isolated from the Meliaceae
11
.  
The bioactivity of compounds from Meliaceae has been the subject of past 
reviews
12
. Extracts from Ekebergia capensis are important in Zulu traditional medicine 
in South Africa, being used to induce or facilitate labour in pregnant women and have 
been shown to have uterotonic activity
13
. Bark from both Trichilia dregeana and 
Trichilia emetic is used to procure abortions and is used as a fish poison in Zimbabwe
14
. 
Preparation from Neem tree (Azadirachta indica) are used to treat a wide range of 
conditions and the plant yields the insect anti-feedant compound azadirachtin
12
. The 
neem, or nim tree is also called the margose tree, grown throughout the Old World 
tropics, notably in India and Southeast Asia, as a source of timber and medicinal oils 
and resin. 
1.4 GENUS WALSURA 
The genus Walsura comprising about 40 species and varieties is mainly distributed 
in Southeast Asia and China
15
. Previous studies on this species have resulted in the 
isolation of various compounds such as, triterpenoids and tetranortriterpenoids with a 
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1.5 OBJECTIVES OF STUDY 
The objectives of this study are as follows: 
I. To isolate the chemical constituents from Walsura pinnata Hassk. 
II. To perform fractionation and isolation of chemical constituents from the 
plants samples using chromatographic techniques. 
III. To identify each isolated constituents by means of spectroscopic method 
such as NMR, IR, and MS. 
IV. To perform cytotoxicity assay on selected pure compounds using various 
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The following sections will discuss briefly some of terpenoids. The genus Walsura are 
known to produce a variety of chemical compounds such as triterpenoids and 
tetranortriterpenoids. 
2.1 TERPENOIDS 
 Terpenoids are structurally diverse group of natural products. More than 25000 
representatives with a variety of biological functions have been reported in the plant 
kingdom such as carotenoids serve as light-harvesting and light-protecting pigments, 
sterols play an important role as modulators of membrane properties, the phytol side 
chain of chlorophyll (the most abundant organic pigment) is of terpenoid origin, and a 
wide variety of plant terpenoids function as insect attractants or repellants
25
. Various 
terpenoids have attracted commercial interest as pharmaceuticals or nutraceuticals. 
Terpenoids are a unique group of hydrocarbon based natural products whose structure 
may be derived from isoprene 6. So, terpenes are classified as follows by starting from  
5 carbon units as shown in Table 2.1 
Table 2.1 : Classification of Terpenes 
Bil Number of Carbon Class Example 
1 5 Hemiterpenes β – Furoic acid 7, Angelic acid 8 
2 10 Monoterpenes Cineole 9, Carane 10 
3 15 Sesquiterpenes Guaiol 11, α – Cadinene 12 
4 20 Diterpenes Phytol 13, Marrubin 14 
5 30 Triterpenes Cucurbitacin D 15, α–Amyrin 16 
6 40 Tetraterpenes Lutein 17 
 
 














































Like all natural products, within this simple classification lies an enormous 
amount of structural diversity, which leads to a wide variety of terpene like compounds. 
The simplest examples of the terpenes are technically hydrocarbons. The terpenes are of 
a similar biogenetic origin, in which repetitive addition of isopentyl pyrophosphate 
(IPP) and dimethylallyl pyrophosphate (DMAPP) combine produces geranyl 
pyrophosphate (GPP), farnesyl pyrophosphate (FPP), and geranylgeranyl diphosphate 
(GGPP). Two molecules of FPP on addition give triterpenes whereas addition of two 
molecules of GGPP gives tetraterpenes (Scheme 2.1). These various combinations and 
oxidations give rise to a large variety of terpenes.  
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 The C15 sesquiterpenes was derived from three isoprene units and exist in a wide 
variety of forms, including linear, bicyclic and tricyclic frameworks. Most of the 
sesquiterpenes are considered to be essential oils because they belong to the steam 
distillation fraction often containing the characteristic odoriferous components of the 
plant. Some common sesquiterpenes are shown in Figure 2.2 such as bisabolenes, 
cadinenes, humulenes, santonins and etc. 
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 The santonin 27 is an antihelminthic that is isolated from wormwood (Artemisia 
maritima). Caryophyllene 22, first synthesized in 1964, is one of the principal 
components of oil of cloves. Helenalin 29 is one of numerous pseudoguaianolide 
sesquiterpene lactones isolated from arnica oil (Arnica Montana). Acorone 30 is a 
sesquiterpene diketone present in the essential oil of sweet flag (Acarus calamus). The 
sesquiterpene α-cadinene 19 is one of the more than 70 isolated compounds from the 
essential oil of juniper berries. Finally, tetrahydroridentin B 28 is one of the bitter 
eudesmolide unique to the common dandelion (Taraxacum officinale). 
The biosynthesis of sesquiterpenes can be discussed as follows: a) 
sesquiterpenoids from cis,trans-farnesyl pyrophosphate with initial closure at 6,7-
double bond 33, b) sesquiterpenoids from cis,trans-farnesyl pyrophosphate with initial 
closure at 10,11-double bond of 34 and c) sesquiterpenoids from trans,trans-farnesyl 
pyrophosphate 37. The typical sesquiterpene skeletons and their biogenetic relationship 
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The following sub-chapter shall discuss briefly about cadinane and aromadendrane type 
of compounds. 
2.2.1 CADINANE GROUP 
The biosynthesis of the cadinane skeleton (Scheme 2.2.1) which can be derived 
from carbonium ions 36, this in turn arise from cis, trans-farnesyl pyrophosphate 32 via 
the non-classical ion 34. This skeleton can also be established by synthesis (Scheme 
2.2.1) in racemic form using a key photochemical step that lead to the formation of ring 















































































The farnesyl carbocation 48 (Scheme 2.2.2) in which both double bonds are in 
the trans configuration, can add to the 10,11-double bond, either at the 11-carbon to 
give trans humalane 49 or the 10-carbon to give the germacrane 50 skeleton and third 
Squamulosone 47
O











































possibility is to insert into the 10,11-double bond to give a cyclopropane ring. The ring 
strain in the resultant material can be relieved by trans annular cyclization 51 to give the 

















Triterpenoids form the largest and most widely distributed terpenoids class. For 
the most part they have four or five rings, with double bonds, hydroxyl, carboxyl, 
ketonic groups, acetoxyl group, oxide ring, lactone and acid groups. They occur 
mainly in plants, often as esters or glycosides, but the class also includes most of the 
few known terpenoid substances of animal origin. 
 Most triterpenoids fall into one of two major classes, which is tetracyclic series 
of non-isoprenoid compounds structurally related to the steroids, (trimethylsteroids), 
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some of which have 31 carbon atoms and a very large pentacyclic class comprising a 
number of skeletal types (Scheme 2.3) and some of their skeleton are depicted in 
Figure 2.3. The second class is called ‘nortriterpenoids’, which possess less than 30 























R2 R1 Ursane 61
Taraxasterane 60
R1=CH3, R2=H Oleanane 56
R1=H, R2=CH3 Taraxerane 57
R1=H, R2=CH3 Glutinane 58





































































Figure 2.3: Some examples of triterpenoids skeleton. 
cabraleadiol 62 ( dammarane)
19
 
acantrifoside A 63 (lupane)
23
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The following paragraphs shall discuss briefly about the subgroups of related 
triterpene. 
2.4 PENTACYCLIC TRITERPENOIDS 
Pentacyclic triterpenes constitute an important group of natural compounds. 
They are obtained from plants and especially from bark of trees such as plane, cork and 
birch but also in liquorice roots where they are particularly abundant. Pentacyclic 
triterpenoids based on the oleanane, lupane and related skeletons have provided some of 
the most useful markers for inputs of organic matter from terrestrial plants to marine 
sediments. For example, β-amyrin and taraxerol and their degradation products were 
used as tracer of organic matter from mangroves in sediments from Florida Bay
30
. 
Its also contributes to the development of modern therapeutics drugs. Their 
biological properties are considerable
31
. For example, betulinic acid and ursolic acid 
have been shown to exhibit significant anticarcinogenic and anti-HIV activity
32,33
, 
lupeol is a competitive inhibitor of both trypsin and chymotrypsin
34
 and the 
antiphlogistic activity of betulin was confirmed in various experimental models
35
. α-
amyrin and β-amyrin have been patented for use in cosmetic industries as hair and skin 
protecting agent
36
. More than 200 triterpenoids containing different carbon skeletons 








































R=COOH Oleanolic acid 71
R=CH3 β-amyrin 72
The following sub-chapter shall discuss briefly three type of pentacyclic 
triterpenes ; oleanane, ursane and lupane types. 




The parent hydrocarbon of this, the largest pentacyclic group, is oleanane which 
takes its name from oleanolic acid 71, a constituent (as a glycoside) of olive leaves, 
mistletoe and cloves. Historically, the series derived from β-amyrin 72, which was 
originally isolated in the nineteenth century from elemi resin, and is widespread in 
plants, both free and as esters, for example in grape seeds and alfalfa. 
 Oleanane derivatives (Scheme 2.4.1) are numerous and widespread in nature, 
and differ structurally in their degree and position of oxygenation. The C-3 oxygen 
function is universally present and the C-12, C-13 double bond almost so the former 
function usually takes the form of a β-hydroxyl group, but the α-configuration is 
sometimes found, and some ketones are known. About 80 percent of natural oleananes 
are oxygenated at C-28, which is most commonly a carboxyl group, but may be a 
hydroxymethyl or, occasionally, an aldehyde group. Similar oxygenation is common at 
C-23, and occasionally found at C-30. Additional hydroxyl groups are commonest at C-
2 and at C-16, and occur occasionally in other positions, notably C-21 and C-22
38
. A 
few lactones and epoxides are also known.  
 
 



















































Oleanane, R= H 56
R= Ac 79
taraxerol, R= H 80
R= Ac 81
















































α-Amyrin 86 has many natural sources, and occurs in Manila elemi resin along 
with β-amyrin, from which it differs only in ring E; indeed the two compounds are so 
similar in properties that they were originally believe to be stereoisomers. The 
triterpenoid of the ursane series arise, from the chair-chair-chair-boat unfolded 
conformation 87 of squalene via the non-classical ions 88. For the sake of clarity and 
simplicity, the transformations leading to the construction of rings D and E are best 
illustrated by two dimensional formulae and for the most part, simple carbonium ions 










Thus oxidative cyclization of squalene 87 to 89, followed by ring enlargement, 
gives 90, which cyclises to non-classical ion 91. This giving 92, which converted by 
methyl and hydride shifts and deprotonation into α-amyrin 86 shown in  Scheme 2.4.2b. 
 
 
























Scheme 2.4.2b: Cyclization of squalene to give ursane skeleton
39
. 





Lupeol 96, was isolated from lupin seeds, and is very widely distributed in 
plants. The lupane skeleton arises by the same biosynthetic processes as the ursane and 
oleanane skeletons, (Scheme 2.3) and lupeol 96 is derivable by proton elimination from 
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2.5 CHEMICAL CONSTITUENTS OF THE GENUS WALSURA  
Walsura Species Compounds Reference 




Piscidinol B 98 
Piscidinol C 99 
Piscidinol D 
Piscidinol E 




Walsuranoid A 101 
Walsuranoid B 102 





Walsucochin A 104 

















Table 2.5 : Chemical constituents of Genus Walsura. 
 
 























































































































































































Nine known compounds have been isolated from the bark of Walsura pinnata Hassk (KL 
4571), which was collected from Kuala Lipis, Pahang. The isolation of pure compounds 
was accomplished through chromatographic methods; TLC and CC the structures of the 
isolated compounds were then elucidated by NMR (nuclear magnetic resonance), LCMS 
(liquid chromatography mass spectrometry) and IR (infrared) spectroscopy. Discussion on 
the structural elucidation of all the isolated compounds is represented in the following 
section of this chapter.  
 
3.1 Compound A : ledol 115 
 
 
Compound A, was isolated as gummy oil. The EIMS spectrum showed the molecular ion 
peak at m/z 204[M
+
] corresponding to formula C15H26O. The IR spectrum of compound A 
displayed absorption bands at 3381 cm
-1
 due to the absorption of hydroxyl group. 
 
The 1H NMR spectrum (Figure 3.1.1) disclosed three tertiary methyl groups at δH 
0.96;CH3-12, 1.02; CH3-13 and 1.12; CH3-14 and one doublet methyl group at δ 0.93;CH3-
15 (J=6.9Hz). A very shielded dd δH0.31 (J=10.5, 5.9 Hz, H-6) and a ddd δH0.71 (J=15.1, 
9.1, 5.9Hz, H-7) were observed and corresponds to the cyclopropane protons. These signals 
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are characteristic of aromadendrane-type sesquiterpenes. The spectral data, coupled with 




C NMR spectrum (Figure 3.1.2) combined with analysis of the DEPT spectrum 
(Figure 3.1.3) permitted differentiation of 15 resonances into two quaternary carbons, five 
methines, four methylenes, three tertiary methyls and one secondary methyl, of which were 
assigned to a sesquiterpene skeleton. 
 
After direct 1H and 13C correlations were established from the HSQC spectrum (Figure 
3.1.4), the gross structure of compound A was elucidated on the basis of the analysis of 
HMBC spectrum (Figure 3.1.5). The location of secondary methyl group between CH3-15 
and C-3 was demonstrated by the HMBC correlations from CH3-15(δH0.93) to C-3(δC30.8) 
and CH3-15 to C-5 (δC38.5) indicated the connectivity between C-4 and C-5. The presence 
of a dimethylcyclopropyl group at C-6 and C-7 was exhibited by the HMBC correlations of 
CH3-13 (δH1.02) with C-7 (δC25.1) and C-11 (δC19.3) and of CH3-12 (δH0.96) with C-6 
(δC23.4) and C-11(δC19.3). Finally, the HMBC correlations between CH3-14(δH1.12) and 
C-1(δC53.8), C-10(δC74.7), and C-9(δC39.2), confirming C1-C10-C-14 and C1-C10-C9 
connectivities. The structure of compound A is thus confirmed to be ledol46. The complete 










                       Figure 3.1a : Significant HMBC (→) interaction of Compound A 




C and HMBC Spectral Data of Compound A in CDCl3 
Position  δC (ppm) δH [ppm (J,Hz)]   HMBC(H→C) 
1  53.8  2.07(m)     
2  24.7  1.68(m)    14   
    1.83(m) 
3  30.8  1.27(m)    15 
    1.70(m) 
4  38,5  1.97(m)    1 
5  40.8  1.77(m) 
6  23.4  0.31(dd, J=10.5, 9.1Hz)  5, 13 
7  25.0  0.71(ddd, J=15.1, 9.1, 5.9Hz)  12 
8  20.4  1.21(m)    12 
    1.88(m) 
9  39.2  1.69(m)    10 
    1.84(m) 
10  74.7   
11  19.3   
12  15.5  0.96(s)     7, 11, 13 
13  28.7  1.02(s)     6, 11, 12 
14  30.5  1.12(s)     1, 9, 10,  
























































Figure 3.1.3: DEPT  Spectrum of Compound A 
  
 
 Figure 3.1.4:  HSQC Spectrum of Compound A 
  
 
 Figure 3.1.5: HMBC Spectrum of Compound A 
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3.2 Compound B : oplopanone 116 
 
Compound B was obtained as colourless gummy oil. The IR spectrum showed absorption 
bands at 3376 and 1706cm
-1 
due to OH and C=O functional groups, respectively. The 
GCMS analysis gave the protonated molecular ion peak at m/z 238 corresponding to the 
molecular formula C15H26O2, implying thus three degrees of unsaturation. 
 
The 1H NMR spectrum (Figure 3.2.1) and 13C NMR spectrum (Figure 3.2.2) of compound 
B was characterized with a tertiary methyl group (δH1.19; δC20.4, CH3-14), one isopropyl 
group [(δH1.44; δC29.6, H-11), (δH0.68, J=6.8Hz; δC15.7, CH3-13), (δH0.88, J=6.8Hz; 
δC22.1, CH3-12)], a doublet of doublet of doublets at( δH2.65, J=14.6, 9.6, 5.4Hz; δC55.8, 





The HMBC spectrum showed a correlation between (Figure 3.2.4) the singlet methyl 
proton signal of CH3-15(δ2.18), carbonyl carbon signal C-5(δC211.7) and C-4(δC55.8). 
Moreover the singlet methyl proton signal of CH3-14(δH1.19) showed cross peaks with the 
carbon signal of C-10(δC73.2) bearing hydroxyl group, methylene carbon signal of C-
9(δC42.1) and methine carbon signal C-1(δC57.1). In addition, correlations were observed 
between the methyl protons CH3-12(δH0.88) and CH3-13(δH0.68) with the carbons C-
11(δC29.6) and C-7(δC49.5). The remaining proton signals were assigned by the HSQC 
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spectrum (Figure 3.2.3). On the basis of these data, the proton and carbon chemical shifts of 
compound B were completely assigned as the cadinane type sesquiterpene oplopanone
47
in 
Table 3.2 and Figure 3.2a 
 
                         Figure 3.2a : Significant HMBC (→) interaction of Compound B 




C and HMBC Spectral Data of Compound B in CDCl3 
Position  δC (ppm) δH [ppm (J,Hz)]    HMBC(H→C) 
1  57.1  1.44(m)    
2  25.4  1.40(m)    4 
    1.80(m) 
3  28.7  1.56(m)    4 
    1.93(m) 
4  55.8  2.65(ddd, J=5.4, 9.6, 14.6Hz)     
5   211.7   
6  46.8  1.88(m) 
7  49.5  1.10(m)    13 
8  23.1  1.08(m) 
    1.56(m) 
9  42.1  1.30(m)    14 
    1.76(m) 
10  73.2 
11  29.6  1.44(m) 
12  22.1  0.88(d, J=6.8Hz)   7, 11, 13 
13  15.7  0.68(d, J=6.8Hz)   7, 11, 12 
14  20.4  1.19(s)     1, 9, 10 























HNMR Spectrum of Compound B 
  
 
   
Figure 3.2.2: 
13
CNMR Spectrum of Compound B 
  
 
   




































Figure 3.2.5:HMBC Spectrum of Compound B 
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Compound C : Betulonic acid 117   
 
Compound C displayed a molecular ion peak at m/z 453.61 in the LCMS, and in agreement 
with the molecular formula of C30H46O3. The IR spectrum of compound C showed 
absorption bands at 3072-2870 cm
-1
(COOH) and 1694 cm
-1




H NMR spectrum (Figure 3.3.1) of compound C exhibited five singlets of five tertiary 
methyl groups at δH0.90, 0.95, 0.96, 0.99 and 1.04 ppm corresponding to CH3-25, CH3-26, 
CH3-27, CH3-24 and CH3-23. Futher signals were observed at δH1.67 (CH3-30), 4.72ppm 
(Hb-29), and 4.59(Ha-29), indicating the presence of an isopropenyl group in the structure 




C NMR spectrum (Figure 3.3.2) displayed resonances at δ 218.4 and 181.5 which can 
be assigned to C-3, and C-28, respectively. The resonances at δ 19.5(C-30), 109.9(C-29) 
and 150.5(C-20) may be attributed to the isopropenyl group. This signal correlated with the 
signal at δH2.97(H-19) in the HMBC spectrum (Figure 3.3.5). The results indicated that 
compound C is the lupane type triterpene, having a 3-keto group. 
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 In addition to 
13
C NMR spectrum and  DEPT spectrum (Figure 3.3.3) revealed the 
presence of six methyls, eleven methylenes, five methines and eight quaternary carbons 
which provided further evidence for a pentacyclic triterpene skeleton. The ∆
20,29
-
functionality of a lupane skeleton was inferred for this compound from the resonances of 
sp
2 
carbons at C-29 (secondary carbon signal deduced by DEPT pulse sequence) at δ 109.9 
and C-20 (quaternary carbon) at δ 150.5. The analysis of the NMR spectrum (Figure 3.3a) 
and complete assignment of all the protons and carbons (Table 3.3) by 1D and 2D NMR 
spectra confirmed that compound C is betulonic48. 
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C and HMBC Spectral Data of  Compound C in CDCl3 
Position  δC (ppm) δH [ppm(J,Hz)]  HMBC(H→C) 
1  39.8  1.31(m)   2, 3, 5, 6, 25 
    1.87(m)    
2  34.3  2.40(m)   1, 3 
3  218.4      
4  47.5 
5  55.1  1.30(m)   6 
6  19.8  1.50(m)     
7  33.8  2.20(m)     
    2.27(m) 
8  40.8  
9  50.0  1.34(m)   8, 10,   
10  37.2   
11  21.5  1.40(m) 
12  25.7  2.98(m)    
13  38.7  2.24(m)     
14  42.7 
15  29.8      28 
16  32.3  1.50(m)     
    1.96(m) 
17  56.5 
18  49.4  1.60(m)   13, 17, 19 , 20, 28 
19  47.0  2.97(m) 
20  150.5   
21  30.7  1.40(m)   18, 28 
    2.00(m) 
22  37.1    
23  26.8  1.04(s)    3, 4, 5, 24 
24  21.2  0.99(s)    3, 4, 5, 23 
25  16.0  0.90(s)    5, 9 
26  16.1  0.95(s)    7, 9, 14 
27  14.8  0.96(s)    8, 15,  
28  181.5   
29  109.9  4.59(br s)   21, 30 
    4.72(br s) 



















































































Figure 3.3.3: DEPT  Spectrum of Compound C 
  
 
   
 
























Figure 3.3.5: HMBC Spectrum of Compound C 
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Compound D was isolated as white crystals with mp 178
o
C. The ESI-LCMS showed an 
(M)
+
 ion peak at 454 ,supported the molecular formula of C30H47O3 which indicated eight 
degrees of unsaturation. The IR spectrum of compound D showed an absorption bands at 




The 1H NMR spectrum (Figure 3.4.1) exhibited seven methyl singlets (δH0.81;CH3-26, 
0.90;CH3-29, 0.93;CH3-30, 1.03;CH3-24, 1.04;CH3-25, 1.08;CH3-23, and 1.11;CH3-27), 







C NMR (Figure 3.4.2) displayed 30 carbons signals including seven methyls (δC 
15.0;C-25, 16.9;C-26, 21.4;C-24, 23.5;C-30, 25.8;C-27, 26.4;C-23 and 33.0;C-29) and two 
olefinic carbons (δC122.3 and 143.6), which were typical of the double bond at C-12 and C-
13 of oleanane type triterpenes. Signal at δC182.9(C-28) indicated the presence of 
carboxylic group. In addition, chemical shifts of C-17, C-18, C-19, C-20 and C-22 at δC 
46.5, 41.0, 45.8, 30.6 and 32.3 respectively suggested that compound D belongs to the β-
amyrin series of pentacyclic
49
.  
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These observations were further confirmed by the correlations detected in the HMBC 
spectrum (Figure 3.4.4) between H-18(δH 2.83) and C-11(δC 22.9), C-19(δC 45.8), C17(δC 
46.5), C-12(δC 122.3), C-13(δC 143.6) and C-28(δC 183.0), giving an evidence that the 
double bond group at C-12 and C-13, and carboxyl group at C-28. Detail analysis of 
HMBC spectrum allowed the assignment of all the 
1
H NMR and 
13
C NMR signals, 
confirming the structure of compound D as the oleanane type triterpene called as oleanonic 
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C and HMBC Spectral Data of Compound D in CDCl3 
Position  δC (ppm) δH [ppm(J,Hz)]  HMBC(H→C) 
1  39.1  1.27(m)   3 
2  34.1  2.45(m)   3 
    2.52(m) 
3  217.7 
4  47.4 
5  55.3  1.18(m)   23, 24, 25 
6  19.5  1.24(m)   
    1.38(m) 
7  32.4  1.59(m)   26, 27 
8  39.3     
9  46.9  1.49(m) 
10  36.8 
11  22.9  1.84(m)   12, 13 
    1.78(m) 
12  122.3  5.30(br s)   14, 16, 17 
13  143.6 
14  41.7 
15  27.6  1.51(m)   13, 16 
    1.58(m)   
16  23.5  1.35(m)   15 
    1.56(m) 
17  46.5 
18  41.0  2.83(dd, J=13.9, 3.6Hz) 11, 12, 13, 17, 19, 28 
19  45.8  1.72(m)   18 
20  30.7 
21  33.8  2.29(m) 
    2.52(m) 
22  32.2  1.37(m)   18 
    1.42(m) 
23  26.4  1.08(s)    3, 4, 5 ,24 
24  21.4  1.03(s)    3, 4, 5 ,23 
25  15.0  1.04(s)    10 
26  16.9  0.81(s)    8, 9, 14 
27  25.8  1.11(s)    8, 14 
28  183.0 
29  33.0  0.90(s)    19, 20, 21, 30 









  Figure 3.4.1: 
1







































   
Figure 3.4.2: 
13
CNMR Spectrum of Compound D 
  
 







Figure 3.4.3: DEPT Spectrum of Compound D 
  
 
   
Figure 3.4.4: HSQC Spectrum of Compound D 
  
 
   Figure 3.4.5: HMBC Spectrum of Compound D 
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Compound E was obtained as gummy oil and had a molecular formula of C30H44O3, 
established by the EIMS spectrum (M
+
, m/z 452). The IR spectrum of compound E showed 
an intense bands at 1765, 1705 and 1640 cm-1 assigned to a γ-lactone, a six membered ring 




H NMR spectrum (Figure 3.5.1) data of compound E were similar to those of 
compound D. In addition, there were other significant peaks at δH5.45 (dd, J = 10.3, 3.2 






C NMR spectrum (Figure 3.5.2) of compound E exhibited signals at δC 216.9(C-3), 
135.3(C-11), 127.4(C-12), 89.6(C-13) and 180.0(C-28). This spectral feature indicate that 
compound E belongs to an oleanan-28,13β-olides system.  
 
The CH3-23 (δH1.08) and the CH3-24 (δH1.03) had distinct HMBC (Figure 3.5.3) 
correlations with the sole carbonyl signal δC216.9(C-3) signal. In the HMBC experiment as 
summarized in Figure 3.5a, the methylene, CH2-15 (δH1.20) signals showed cross peaks to 
the oxygen-bearing quaternary carbon signal at δC89.6(C-13), which in turn correlated to 
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the olefinic proton signal at δH6.03 (H-12). Thereby, the disubstituted double bond must be 
placed at the ∆
11,12
 position on the C-ring of the oleanane, and also in consideration of eight 
degrees of unsaturation, the 6 membered ring should be formed via a lactone linkage 


























































Results and Discussion  Chapter 3 
60 
 




C and HMBC Spectral Data of Compound E in CDCl3 
Position  δC (ppm) δH [ppm(J, Hz)]   HMBC(H→C) 
1  39.0  1.34(m)   3  
    2.10(m)     
2  33.9  2.44(ddd, J=16.0, 6.8, 3.7Hz)  1, 3   
    2.65(ddd, J=16.0, 11.4, 7.3Hz)  
3  216.9       
4  47.7         
5  54.7  1.32(m)    25   
6  18.9  1.58(br s) 
7  30.5  1.23(m)    6   
    1.41(m) 
8  41.5        
9  52.6  1.98(m)    8, 10, 11, 12, 25 
10  36.1        
11  135.3  5.45(dd, J=10.3, 3.2Hz)  9, 14 
12  127.4  6.03(dd, J=10.3, 1.3Hz)  13, 14  
13  89.6 
14  41.5 
15  25.4  1.20(m)    13, 14, 26 
    1.72(m) 
16  21.3  1.29(m)    17, 28 
    2.07(m) 
17  44.0 
18  50.6  2.06(m) 
19  37.4  1.34(m)    16, 18, 20, 30 
    1.79(m) 
20  31.5 
21  34.4  1.29(m) 
22  27.1  1.63(m)    13 
23  26.0  1.08(s)     4, 5, 24 
24  20.9  1.03(s)     4, 5, 23 
25  17.3  1.04(s)     10, 
26  18.2  1.03(s) 
27  18.7  1.08(s)     7, 8, 13 
28  180.0 
29  33.3  0.96(s)     19, 20, 21, 30 
























   
Figure 3.5.1: 
1










































































































Figure 3.5.5: HMBC Spectrum of Compound E 
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Compound F was isolated as a gummy solid. Its molecular formula C30H46O4  was 
determined by EIMS m/z 470 (M
+
). The IR spectrum of compound F displayed absorption 
at 3619, 1760, 1699 cm
-1 
assigned to hydroxyl group, γ lactone, and a six membered ring 
ketone respectively.  
 
The 1H NMR spectrum (Figure: 3.6.1) and 13C NMR spectrum (Figure: 3.6.2) 
spectroscopic data of compound F were similar to those of compound E except for the 
presence of a hydroxyl group in compound F instead of the double bond group found in 
compound E. Moreover, the signal at δH3.88 (H-12) attributed to the CH-OH group in the 






C NMR spectrum (Figure: 3.6.2) displayed resonances at δC 217.7 , 
76.3, 90.6 , and 179.8 which were assigned to C-3, C-12, C-13 and C-28 respectively which 
suggesting the presence of a 13β, 28 olide and 12-hydroxyl group.  
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This was further corroborated by the HMBC spectrum (Figure: 3.6.3), whereby the proton 
signal at δH3.88(H-12) correlated with C-13 (δC90.6) and C-18 (δC43.9) confirmed the 12α-
hydroxy-3-oxooleanano-28,13-lactone structure
54
 of compound F. The below assignments 
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C and HMBC Spectral Data of Compound F in CDCl3 
Position  δC (ppm) δH [ppm(J,Hz)]  HMBC(H→C) 
1  39.6  1.87(m)   25 
2  34.2  2.4-2.5(m)   1, 3 
3  217.7 
4  47.4 
5  54.4  1.34(m)   
6  19.1  1.46(m)   25 
7  33.4  1.25(m) 
8  42.2   
9  51.2  1.99(m)   4, 5, 8 
10  36.2 
11  21.2  2.11(m)   18 
12  76.3  3.88(s)    13, 18 
13  90.6 
14  42.2 
15  29.1  2.01(m)   9, 12, 14, 17, 28  
    1.45(m) 
16  27.5  1.59(m) 
17  47.4 
18  43.9  1.70(m)   14, 15, 19, 27 
19  39.5  1.42(m)   14, 20, 22 
20  31.6 
21  34.0  1.28(m) 
22  28.1  1.14(m)   17, 18, 20, 21 
23  26.7  1.07(s)    3, 4, 5, 24 
24  21.1  1.02(s)    3, 4, 5, 23 
25  16.3  0.96(s)    5 
26  18.2  1.16(s)    7, 13, 14 
27  18.5  1.29(s)    8, 9, 13, 15 
28  179.8 
29  33.3  0.96(s)    18, 19, 20, 21 










































































   
Figure 3.6.2: 
13



































   


















Figure 3.6.5: HMBC Spectrum of Compound F 
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3.7 Compound G : 3-oxoursolic acid 121 
 
Compound G was obtained as a white amorphous powder. Its was considered to be a 





H NMR and 
13
C NMR (Table 3.7) together with the fact that the molecular formula, 
C30H47O3, consistent with eight degrees of unsaturation. Its IR spectrum showed absorption 
bands at 3400-2920, 1695 and 1670 cm
-1
 assigned to a hydroxyl acid, a six membered ring 
ketone and a double bond groups respectively. 
 
In 1H NMR spectrum (Figure 3.7.1) of Compound G was deduced to be an ursane due to 
five singlet methyl groups at δH1.06;CH3-23, 1.06;CH3-25, 1.02;CH3-27, 1.00;CH3-24 and 
0.80;CH3-26 and two as doublets at δH0.84 (J=6.3 Hz;CH3-29) and 0.93 (J=7.8Hz;CH3-
30)
55
. It also showed resonance for an olefinic proton at δH5.23 of H-12 and a characteristic 




In addition , the 
13
C NMR spectrum (Figure: 3.7.2) of compound G revealed the presence 
of seven methyls, nine methylenes, six methine and eight quaternary carbons which 
provided further evidence for a pentacyclic triterpene skeleton. The 13C NMR spectrum of 
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Compound G displayed resonances at δC125.6, 138.1, 184.0 and 217.9 attributable to C-12, 
C-13, C-28 and C-3 respectively.  
 
The HMBC spectrum (Figure :3.7.3),showed correlation between δC125.6(C-12) and 
δC138.1(C-13) with δH2.16[d, J=11.4Hz;(H-18)]. Thorough analysis of 1D and 2D spectra 
of compound G confirmed that it is the known as 3-oxoursolic
55
. The below assignments 
(Figure 3.7a) were made by 2D-NMR (Table 3.7) studies including HMBC (Figure : 3.7.3)  
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C and HMBC Spectral Data of Compound G in CDCl3 
Position   δC (ppm) δH [ppm(J, Hz)]  HMBC(H→C) 
1  39.3  1.27(m)   3 
    1.37(m) 
2  34.2  2.52(m)   1, 3 
    2.36(m) 
3  217.9 
4  47.4 
5  55.3  1.30(m)   6, 7, 23, 24, 25, 
6  19.6  1.45(m)   5 
7  32.5  1.33(m) 
    1.40(m) 
8  39.5 
9  46.8  1.58(m)   1, 11, 14, 26 
10  36.7 
11  23.4  1.96(m) 
    1.99(m) 
12  125.6  5.23(s)    11 
13  138.1      11 
14  42.1  
15  28.0  1.11(m) 
16  24.1  1.60(m)   22 
    1.68(m) 
17  48.0 
18  52.6  2.16(d, J=11.4Hz)  12, 13, 14, 16, 19, 28, 29 
19  39.1  1.85(m)   16 
20  38.8  0.88(m)   29,  
21  30.6  1.50(m)   22 
22  36.7  1.63(m) 
    1.72(m) 
23  26.6  1.06(s)    3, 4, 5, 24 
24  21.5  1.00(s)    3, 4, 5, 23 
25  15.2  1.06(s)    1, 10 
26  17.0  0.80(s)    7, 8, 9, 14 
27  23.5  1.02(s)    8, 13, 14, 15 
28  184.0 
29  17.0  0.84(d, J=6.3Hz)  18, 20, 30 






































































   
Figure 3.7.2: 
13

















   

















   
Figure 3.7.4: HMBC Spectrum of Compound G 
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Compound H is a constitutional isomer of compound E based on its molecular formula of 
C30H44O3 (M
+
 ,m/z:452.33) which was determined from LCMS and 
13
C NMR (Figure: 
3.8.2). Its IR spectrum showed absorption bands at 2634, 2866 (CH), 1765 (lactone C=O), 
1703 (ketone C=O), and 1137 cm-1 (C-O). 
 
Compound H presented spectral data similar to those of ring A of compound G. Its 
1
HNMR 
spectrum (Figure : 3.8.1) showed  five tertiary methyl signals observed as singlets 
δH1.03;CH3-24, 1.04;CH3-25, 1.08;CH3-23, 1.08;CH3-26, 1.15;CH3-27 and two methyls 
were observed as doublets [δH0.99 (J=6.4Hz;CH3-29) and 0.93 (J=6.4Hz;CH3-30)]. In the 
1
H NMR of compound H, 2 vinylic proton signals were observed belonging to H-11 
[δH5.95 (J = 10.5, 1.3Hz)] and H-12 [δH5.57 (J = 10.5, 3.2Hz)] instead of only one vinylic 
proton signal in compound G. This is because the double bond in compound H is on C-11 
and C-12 but in compound G the double bond is on C-12 and C-13. 
 
The structure was finally elucidated from interpretation of its 
13
C NMR spectral data (Table 
3.8) which showed the presence of the signal at δC216.9 attributable to the ketone in 
position C-3. 
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Further analysis on the HMBC spectrum also led to the identification of a signal at δC89.2 
(C-13) which was shown in (Figure: 3.8.3) correspond to an olefinic methine proton at 
δH5.95 (dd, J=10.5, 1.3). The signal at δC180.1 (C-28) was attributed to C-28 because of the 
presence of the lactonic system in ring-D between C-28 carbonyl function and C-13. On the 
basis of the above spectra evidence the structure of compound H was established as 3-
ketours-11-en-13β(28)-olide
56
. The complete assignments (Figure 3.8a) were accomplished 
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C and HMBC Spectral Data of Compound H in CDCl3 
Position  δC (ppm) δH [ppm(J,Hz)]  HMBC(H→C) 
1  39.1  1.42(m) 
    2.08(m) 
2  34.0  2.42(m)   1, 3 
    2.60(m) 
3  216.9 
4  47.7 
5  54.7  1.32(m) 
6  18.9  1.54(m) 
7  30.6  1.56(m) 
    1.24(m) 
8  41.7 
9  52.5  2.04(m)   11, 12, 25 
10  36.2 
11  132.9  5.95(dd, J=10.5, 1.3Hz) 8, 13 
12  129.4  5.57(dd, J=10.5, 3.2Hz)  
13  89.3 
14  42.0 
15  25.6  1.20(m)   13 
    1.73(m) 
16  22.8  1.39(m)   28 
    2.14(m) 
17  45.1 
18  60.6  1.64(d, J=12.4Hz)  12, 13, 14, 16, 17, 19  
19  38.2  1.76(m) 
20  40.3  0.86(m) 
21  30.9  1.42(m) 
22  31.5  1.52(m) 
    1.80(m) 
23  26.0  1.08(s)    3, 4, 5, 24 
24  20.9  1.03(s)    3, 4, 5, 23 
25  17.3  1.04(s)    1, 9, 10 
26  18.7  1.08(s)    7, 9, 13, 14 
27  16.1  1.15(s)    8, 13, 15 
28  180.1 
29  17.9  0.99(d, J=6.4Hz)  18, 20 





































































   
Figure 3.8.2: 
13



































   

















   
Figure 3.8.5: HMBC Spectrum of Compound H 
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Compound I was isolated as a colourless crystals, mp 305-307
o
C. Its IR spectrum showed 
hydroxyl absorption at 3430 cm
-1
. The EIMS gave a molecular ion peak at m/z 454 (M
+
), 
corresponding to the molecular formula C30H48O3.  
The 
1
H NMR (Figure : 3.9.1) spectrum showed the presence of seven tertiary methyl 
groups, an olefinic proton showed a signal at δH5.59 corresponding to H-6 indicating the 
double bond between C-5 and C-6, and a broad singlet appeared at δH3.45 indicating the 
hydroxyl group at C-3. 
The 
13
C NMR (Figure 3.9.2) and DEPT (Figure 3.9.3) experiments showed seven tertiary 
methyls and ten methylene groups, five methines, and eight quaternary carbons, indicating 
these compound is a glutinane type of triterpene57. 
The resonance of CH3-23 at δH1.01 and CH3-24 at δH1.12 coupled with C-3 (δC76.4), the 
hydroxylated carbon confirmed by HMBC spectrum (Figure: 3.9.4). Moreover, the signal 
of methine proton H-18 [δH2.36 (dd, J=13.2. 3.9)] correlated to the signal at δC184.4 (C-28) 
. The presence of a double bond at C-5 and C-6 was confirmed by analysis of HMBC 
correlations. The coupling constants J18,19 = 13.2Hz and J18,19 = 3.9Hz due to the observed 
interaction of H-18 and H-19. The resonance of H-22 at δH2.28, J22,21 = 14.6 Hz and J22,21 = 












































9.2Hz due to the interaction of H-22 and H-21. The structure of Compound I was 
determined to be 3β-hydroxy-5-glutinen-28-oic
58
. The below assignments (Figure 3.9a) 
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C and HMBC spectral Data of  Compound I in CDCl3 
Position  δC (ppm) δH [ppm(J,Hz)]  HMBC(H→C) 
1  18.4  1.38(m) 
    1.53(m) 
2  27.8  1.66(m)   1, 3  
3  76.4  3.45(br s)   1, 5, 24, 25 
4  40.8  
5  141.5 
6  121.8  5.59(d, J=5.8 Hz)  4, 10 
7  23.5  1.16(m) 
    1.79(m) 
8  47.8  1.48(m) 
9  35.1  
10  49.4  2.02(m)    
11  34.5  1.17(m)    
    1.28(m) 
12  30.9  1.42(m) 
13  38.7  
14  37.2 
15  32.5  1.23(m) 
16  35.9  1.45(m) 
17  44.8      
18  37.8  2.36(dd, J=13.2, 3.9 Hz) 14, 28 
19  34.9  1.50(m) 
20  28.5 
21  32.8  1.41(m) 
22  29.3  2.28(dd, J=14.6, 9.2 Hz) 17 
23  29.0  1.01(s)    3, 4, 5, 24 
24  25.5  1.12(s)    3, 4, 5, 23 
25  15.7  0.80(s)    10, 11  
26  20.3  0.89(s)    8, 18 
27  18.3  0.96(s)    11, 14 
28  184.4      18 
29  34.4  0.91(s)    30 



































































   
Figure 3.9.2: 
13

























































4.0 Cytotoxicity Assay 
 
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) is a yellow 
tetrazolium salt that is reduced to purple formazan by dehydrogenases of a live cell. The 
assay is based on the principle that the amount of formazan produced is directly 
proportional to the number of live cells
59
. It can be used to determine cytotoxicity of 
potential medicinal agents. 
 
MTT assay were performed to investigate the inhibition of cell viability and the 
potential cytotoxicity by crude hexane and its two pure compounds; betulonic acid 
(117) and 3β-hydroxy-5-glutinen-28-oic acid (123), on four human derived carcinoma 
cell lines breast (MCF-7), nasopharyngeal HSC2, cervical (CaSki) and liver (HepG2) 
tumor cell lines as well as in normal cell line, HMEC. The IC50 values were calculated 
in microgram per microlitre (µg/µl). HMEC was used as a control to ascertain that the 
compound used did not show any adverse reactions on normal cells. The IC50 values of 
both compounds betulonic acid (117) and 3β-hydroxy-5-glutinen-28-oic acid (123), 













Table 4.1 IC50 values of hexane extract, betulonic acid (117) and 3β-hydroxy-5-
glutinen-28-oic acid (123) on various tumor cell lines at  24 hour incubation period. 
Compound Cell lines IC50 value 



























MCF7 and HSC2 showed highest cytotoxicity when treated with betulonic acid (117) at 
12 µM and 13 µM respectively. While HepG2 showed the highest degree of sensitivity 









































 The chemical study of the hexane extract of stem bark Walsura Pinnata Hassk 
provided nine compounds by comparison of their physical and spectroscopic data with 
the literature values; ledol (115), oplopanone (116), betulonic acid (117), oleanonic acid 
(118), 3-oxoolean-11-en-13β(28)-olide (119), 12α-hydroxy-3-oxooleanano-28,13-
lactone (120), 3-oxoursolic acid (121), 3-ketours-11-en-13β(28)-olide (122), and 3β-
hydroxy-5-glutinen-28-oic acid (123). This is the first report on the chemical study of 
this plant species. 
Compounds betulonic acid (117) and 3β-hydroxy-5-glutinen-28-oic acid (123) 
were tested for cytotoxicity on cancer cell lines. Both of them showed potent activity 
against MCF7, HSC2 and HepG2 cell lines. The IC50 of both compounds are 19 µM, 18 
µM on HepG2; 12 µM, 25 µM on MCF-7 and 13 µM, 21 µM on HSC-2 respectively. 
Further works may constitute isolation and purification of dichloromethane extract and 
methanol extract and some mechanism investigation can be done for the cytotoxic 





















6.1 GENERAL METHODS 
IR spectra were obtained using Perkin Elmer 16000 Series FT-IR 
spectrophotometer. Mass spectra data were recorded using Hewlett Packard HP 6890 
Series Mass Selective Detector. NMR spectra were recorded using JEOL JNM-FX100 
(400 MHz) and JEOL ECA 400 MHz. Chemical shifts are quoted in ppm (δ) relative to 
CDCl3 as internal standard and coupling constants are in Hz. Column chromatography 
was performed with Kieselgel 60 (Merck), while TLC were performed with Kieselgel 
60F254 (Merck aluminium support plates). Spots were detected under UV light or by 
spraying with 10% H2SO4 followed by heating. 
6.2 CHEMICALS 
 Dulbecco’s modified Eagle’s medium (DMEM) and Roswell Park Memorial 
Institute-1640 (RMPI-1640) with 4.5 g glucose/L, 300 mg/l L-glutamine, 2.5% (v/v) 
trypsin in modified Hank’s balanced salt solution (HBSS) without calcium or 
magnesium, fetal bovine serum (FBS) and all antibiotics were purchased from Lonza 
Inc., USA. MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) 
reagent was purchased from EMD Chemicals Inc. (Calbiochem, San Diego, CA, USA). 
6.3 PLANT MATERIAL 
The stem bark of Walsura pinnata Hassk was collected in March 1996, at 
243km from Gua Musang To Kuala Lipis, Pahang, Malaysia. Identification of the plant 
material was done by Mr. L. E. Teo. A voucher specimen (KL 4571). has been 
deposited at Chemistry Department, Faculty of Science, University of Malaya.  
 
 




6.4 EXTRACTION AND ISOLATION 
 Air-dried, powdered stem bark of Walsura pinnata Hassk (2.3 kg) was 
exhaustively extracted by soaking in n-hexane at room temperature for three days each 
for three times. The extract was filtered and separately reduced to dryness in vacuum to 
obtain the n-hexane extract (25.0 g). The n-hexane extract (10.0 g) was fractionated by 
gravity column chromatography on silica gel using n-hexane, n-hexane-ethyl acetate, 
ethyl acetate-methanol and finally, pure methanol as the mobile phase to yield 10 
fractions. Fraction 2 (0.7 g) was further purified by silica gel column chromatography 
using n-hexane:EtOAc (98:2) as eluent to afford pure compound A (2 mg) whereas 
fraction 5 (n-hexane:EtOAc, 85:15) and fraction 9 (n-hexane:EtOAc, 80:20) afforded 
pure compound C (10 mg) and I (5 mg) respectively. Fraction 6 (0.8 g) was 
subsequently subjected to silica gel column chromatography using n-hexane:acetone 
(96:4) as eluent to afford pure compound E (2 mg). Purification of fraction 7 (3.0 g) on 
column chromatography using n-hexane:acetone (94:6, 93:7, 91:9) led to isolation of 
compound D (2 mg), fraction 7-G (0.1 g) and compound G (2 mg) respectively. 
Fraction 7-G was further chromatographed successively by gravity column 
chromatography using n-hexane:acetone (95:5 and 93:7) to yield compound H (2 mg) 
and compound F (2mg) respectively in pure forms. Finally, fraction 10 (50 mg) was 
separated by CC using n-hexane:acetone (96:4) as eluent to give pure compound B (5 
mg). The isolation and purification procedure was summarized in the flow chart shown 
in Figure 6.4a. 





Figure 6.4a : Flow chart of Isolation and purification. 
6.5 CULTIVATION OF CELLS 
 A total of five tumour cell lines were used in this study. Human breast 
adenocarcinoma (MCF-7) and oral squamous carcinoma (HSC-2 and HSC-4) were 
obtained from the Cancer Research Initiative Foundation (CARIF, Malaysia), while 
human hepatocyte carcinoma (HepG2) and epidermoid cervical carcinoma (CaSki) cells 
were obtained from University Malaya Medical Centre (UMMC, Malaysia). Human 
mammary ephithelial cells (HMEC) (Lonza, USA) were used as normal cell controls. 
All cells were cultured in DMEM except MCF-7 cells which were cultured as 
monolayers in RMPI-1640, supplemented with 10.0% (v/v) FBS, 100.0 U/ml penicillin 
and 100.0 µg/ml streptomycin. Cultures were maintained in a humidified CO2 incubator 
at 37 ºC in 5.0% CO2 and 95.0% air.    




6.6 CELL VIABILITY ASSAY 
 Cell viability was determined using the MTT assay which measures 
mitochondrial activity in viable cells n-hexane crude was dissolved in DMSO to a final 
concentration of 10.0 mM. Briefly, 2.0x10
4
 cells were treated in triplicates on 96-well 
plates in the presence or absence of n-hexane crude at final concentrations of 5.0 µM to 
80.0 µM up to 24 hours. Final DMSO concentration in each experiment was maintained 
below 0.05% (v/v) to prevent solvent induced cytotoxicty. 20.0 µl of MTT dye reagent 
(5.0 mg/ml) was added to each well and cells were incubated in the dark at  37 ºC. After 
2 hours of incubation, the media containing excess dye was aspirated and 200.0 µL of 
DMSO was added to dissolve the purple formazan precipitates. A microtiter plate reader 
(Tecan Sunrise
®
, Switzerland) was used to detect absorbance at a test wavelength of 















6.7 SPECTRAL DATA OF ISOLATED COMPOUNDS. 
Ledol 115   : gummy oil 
Molecular formula  : C15H26O 
IR (cm
-1
)   : 3381 cm
-1
 (3º OH) 
[α]D    : +1.5
o 
(MeOH; c=0.0005)  




CNMR in  CDCl3 : refer Table  3.1 
 
Oplopanone 116  : gummy oil 
Molecular formula  : C15H26O2 
IR (cm
-1
)   : 3376 cm
-1
 (OH), 1706 cm
-1 
(C=O).  
Mass    : m/z 238 
1
H  and 
13











Betulonic Acid 117  : amourphous 
Molecular formula  : C30H46O3 
IR (cm
-1
)   : 3072-2870 cm
-1
(COOH) and 1694 cm
-1 
C=O). 
[α]D    : +42.0
o 
(MeOH ;c=0.0002) 




CNMR in  CDCl3 : refer Table  3.3 
 
Oleanonic acid 118   : crystal mp178
o
C [lit. mp 178-179 
o
C] 
Molecular formula   : C30H47O3 
IR (cm
-1
)    : 2947 cm
-1
 (br, COOH) and    
       1696 cm
-1 
(acid C=O). 




CNMR in  CDCl3    : refer Table  3.4 
 
3-oxoolean-11-en-13β(28)-olide 119 : gummy oil 
Molecular formula   : C30H44O3 
IR (cm
-1
) : 1765 cm
-1
 (lactone C=O), 1705 cm
-1
 (ketone 
C=O), and 1640 cm
-1
 (C=C). 




CNMR in  CDCl3  : refer Table  3.5 




12α-hydroxy-3-oxooleanano-28,13-lactone 120 :gummy oil 
Molecular formula     : C30H46O4 
IR (cm
-1
)     : 3619 cm
-1
 (OH), 1760 cm
-1  




    C=O) 
[α]
23.5
D       : +63.6
o 
(CHCl3 ;c=1.001) 




CNMR in  CDCl3    : refer Table  3.6 
 
3-oxoursolic acid 121  : amorphous 
Molecular formula   : C30H47O3 
IR (cm
-1





       C=O) and 1670 cm
-1
 (C=C). 
Mass     : m/z: 454 
1
H NMR and 
13










3-ketours-11-en-13β(28)-olide 122 : gummy oil 
Molecular formula   : C30H44O3   
IR (cm
-1
)  : 2634, 2866 cm
-1
 (CH), 1765 cm
-1
 (lactone C=O),  
 1703 cm
-1
 (ketone C=O), and 1137 cm
-1
 (C-O). 




CNMR in  CDCl3  : refer Table  3.8 
 
3β-hydroxy-5-glutinen-28-oic acid 123 : Crystal mp 305-307
o
C 
Molecular formula    : C30H48O3.   
IR (cm
-1





D      : +40.3
o 
(CHCl3 ;c=0.0003) 
Mass      : m/z 454 
1
H NMR and 
13
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Key indicators: single-crystal X-ray study; T = 100 K; mean (C–C) = 0.007 A˚;
disorder in main residue; R factor = 0.068; wR factor = 0.204; data-to-parameter
ratio = 10.4.
3-Oxoolean-1-en-28-oic acid, isolated from the bark of
Walsura pinnata Hassk, crystallized from n-hexane as an n-
hexane 0.25-solvent 0.25-hydrate, C30H46O30.25C6H14-
0.25H2O. There are two independent molecules in the
asymmetric unit of the title compound. The three six-
membered cyclohexane rings in each molecule adopt chair
conformations and the carboxyl substituent occupies an axial/
equatorial position. The two independent molecules are
linked by a pair of O—Hcarboxyl  O hydrogen bonds into a
dimer. The n-hexane molecule is disordered about a twofold
rotation axis and the water molecule lies on a twofold rotation
axis. In addition, the cyclohexone carbonyl group of one of the
independent molecules is disordered over two sites with
occupancies of 0.75 and 0.25.
Related literature
There are no reports of chemicals from Walsura pinnata
Hassk. For the action of a fungus on this compound, isolated






a = 28.5864 (7) A˚
b = 12.2408 (3) A˚
c = 19.3545 (4) A˚
 = 120.552 (1)
V = 5832.3 (2) A˚3
Z = 8
Mo K radiation
 = 0.07 mmÿ1
T = 100 K







5441 reﬂections with I > 2(I)
Rint = 0.038
Refinement
R[F 2 > 2(F 2)] = 0.068






max = 0.81 e A˚
ÿ3
min = ÿ0.62 e A˚
ÿ3
Table 1
Hydrogen-bond geometry (A˚, ).
D—H  A D—H H  A D  A D—H  A
O1—H1  O4 0.84 1.71 2.545 (4) 171
O5—H5  O2 0.84 1.83 2.637 (4) 160
O1w—H1w  O3 0.84 2.20 3.03 (2) 169
Data collection: APEX2 (Bruker, 2007); cell reﬁnement: SAINT
(Bruker, 2007); data reduction: SAINT; program(s) used to solve
structure: SHELXS97 (Sheldrick, 2008); program(s) used to reﬁne
structure: SHELXL97 (Sheldrick, 2008); molecular graphics: X-
SEED (Barbour, 2001); software used to prepare material for
publication: publCIF (Westrip, 2009).
We thank the University of Malaya for supporting this
study.
Supplementary data and ﬁgures for this paper are available from the
IUCr electronic archives (Reference: LH2809).
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PG[^W-R[^W-' -%%)%"$--( WNG^WN%^WO' --G)G"$O(
W-I^W-R[^W-' -%%)G"$'( WOO^WN%^WO' --R)R"$O(
W-R^W-'^W-R[ %N)%"$G( WNG^WN%^FN% -&O)&
W-R^W-'^W%& -&')O"$O( WOO^WN%^FN% -&O)&
W-R[^W-'^W%& RR)-"$N( WO'^WN%^FN% -&O)&
W-R^W-'^W%- -&.)'"$N( WN%^WNG^WNO --&)-"$O(
W-R[^W-'^W%- -%I)R"$N( WN%^WNG^FNGo -&').
W%&^W-'^W%- -&.)'"$N( WNO^WNG^FNGo -&').
W-R^W-'^W%% --&)R"$O( WN%^WNG^FNGc -&').
W-R[^W-'^W%% -&I)-"$N( WNO^WNG^FNGc -&').
W%&^W-'^W%% -&R)'"$O( FNGo^WNG^FNGc -&R)%
W%-^W-'^W%% --G)'"$O( WNG^WNO^WNN --O)."$O(
W-'^W%&^F%&o -&')N WNG^WNO^FNOo -&R).
$%&&'()(*+,-."),+(-/,'$
$%&#:8
W-'^W%&^F%&c -&')N WNN^WNO^FNOo -&R).
F%&o^W%&^F%&c -&')N WNG^WNO^FNOc -&R).
W-'^W%&^F%&W -&')N WNN^WNO^FNOc -&R).
F%&o^W%&^F%&W -&')N FNOo^WNO^FNOc -&I).
F%&c^W%&^F%&W -&')N WN.^WNN^WNO -&R)G"$O(
W-'^W%-^F%-o -&')N WN.^WNN^WOG --&)."$G(
W-'^W%-^F%-c -&')N WNO^WNN^WOG --&)N"$G(
F%-o^W%-^F%-c -&')N WN.^WNN^WNI --&)&"$G(
W-'^W%-^F%-W -&')N WNO^WNN^WNI -&')'"$G(
F%-o^W%-^F%-W -&')N WOG^WNN^WNI -&I)N"$G(
F%-c^W%-^F%-W -&')N WNN^WN.^FN.o -&')N
W%G^W%%^W-O ---)I"$G( WNN^WN.^FN.c -&')N
W%G^W%%^W-' --%)&"$G( FN.o^WN.^FN.c -&')N
W-O^W%%^W-' --N)R"$G( WNN^WN.^FN.W -&')N
W%G^W%%^F%% -&N)N FN.o^WN.^FN.W -&')N
W-O^W%%^F%% -&N)N FN.c^WN.^FN.W -&')N
W-'^W%%^F%% -&N)N WO&^WNI^WN' --%)I"$G(
W%O^W%G^W%% -&')."$G( WO&^WNI^WNR -&.)R"$G(
W%O^W%G^F%Go -&')I WN'^WNI^WNR -&.)R"$G(
W%%^W%G^F%Go -&')I WO&^WNI^WNN -&')-"$G(
W%O^W%G^F%Gc -&')I WN'^WNI^WNN -&')-"$G(
W%%^W%G^F%Gc -&')I WNR^WNI^WNN --%)G"$G(
F%Go^W%G^F%Gc -&R)% WNI^WNR^FNRo -&')N
W%G^W%O^W%N --G)N"$G( WNI^WNR^FNRc -&')N
W%G^W%O^F%Oo -&R)' FNRo^WNR^FNRc -&')N
W%N^W%O^F%Oo -&R)' WNI^WNR^FNRW -&')N
W%G^W%O^F%Oc -&R)' FNRo^WNR^FNRW -&')N
W%N^W%O^F%Oc -&R)' FNRc^WNR^FNRW -&')N
F%Oo^W%O^F%Oc -&I)I W.&^WN'^WNI --O)."$O(
W%O^W%N^W%. -&R)R"$G( W.&^WN'^FN'o -&R).
W%O^W%N^W-G --&)O"$G( WNI^WN'^FN'o -&R).
W%.^W%N^W-G --&)O"$G( W.&^WN'^FN'c -&R).
W%O^W%N^W%I -&')R"$G( WNI^WN'^FN'c -&R).
W%.^W%N^W%I --&)%"$G( FN'o^WN'^FN'c -&I).
W-G^W%N^W%I -&I)G"$G( WG%^W.&^WN' --%)N"$G(
W%N^W%.^F%.o -&')N WG%^W.&^F.&o -&')-
W%N^W%.^F%.c -&')N WN'^W.&^F.&o -&')-
F%.o^W%.^F%.c -&')N WG%^W.&^F.&c -&')-
W%N^W%.^F%.W -&')N WN'^W.&^F.&c -&')-
F%.o^W%.^F%.W -&')N F.&o^W.&^F.&c -&I)R
F%.c^W%.^F%.W -&')N W.%^W.-^F.-o -&')N
W-&^W%I^W%' --G)&"$G( W.%^W.-^F.-c -&')N
W-&^W%I^W%R -&.)'"$G( F.-o^W.-^F.-c -&')N
W%'^W%I^W%R -&I)G"$G( W.%^W.-^F.-W -&')N
W-&^W%I^W%N -&R)G"$G( F.-o^W.-^F.-W -&')N
W%'^W%I^W%N -&R)'"$G( F.-c^W.-^F.-W -&')N
W%R^W%I^W%N --%)."$G( W.%^W.G^W.O -&I)&"$'(
W%I^W%R^F%Ro -&')N W.%^W.G^F.Go --&)G
W%I^W%R^F%Rc -&')N W.O^W.G^F.Go --&)G
$%&&'()(*+,-."),+(-/,'$
$%&#:C
F%Ro^W%R^F%Rc -&')N W.%^W.G^F.Gc --&)G
W%I^W%R^F%RW -&')N W.O^W.G^F.Gc --&)G
F%Ro^W%R^F%RW -&')N F.Go^W.G^F.Gc -&R).
F%Rc^W%R^F%RW -&')N W.N^W.O^W.G -&.)."$'(
WG&^W%'^W%I --O)."$G( W.N^W.O^F.Oo --&)O
WG&^W%'^F%'o -&R). W.G^W.O^F.Oo --&)O
W%I^W%'^F%'o -&R). W.N^W.O^F.Oc --&)O
WG&^W%'^F%'c -&R). W.G^W.O^F.Oc --&)O
W%I^W%'^F%'c -&R). F.Oo^W.O^F.Oc -&R).
F%'o^W%'^F%'c -&I). W.-^W.%^W.G --&)R"$-&(
W%'^WG&^W% ---)'"$G( W.-^W.%^F.%o -&')N
W%'^WG&^FG&o -&')% W.G^W.%^F.%o -&')N
W%^WG&^FG&o -&')% W.-^W.%^F.%c -&')N
W%'^WG&^FG&c -&')% W.G^W.%^F.%c -&')N
W%^WG&^FG&c -&')% F.%o^W.%^F.%c -&R)-
FG&o^WG&^FG&c -&I)' W..^W.N^W.O -&')%"$-&(
PO^WG-^PN -%%)&"$O( W..^W.N^F.No -&')R
PO^WG-^WG% -%&)'"$O( W.O^W.N^F.No -&')R
PN^WG-^WG% --I)&"$O( W..^W.N^F.Nc -&')R
WG-^WG%^W.& ---)'"$O( W.O^W.N^F.Nc -&')R
WG-^WG%^WG' -&R)."$G( F.No^W.N^F.Nc -&R)G
W.&^WG%^WG' -&')O"$G( W.N^W..^F..o -&')N
WG-^WG%^WGG -&G)&"$G( W.N^W..^F..c -&')N
W.&^WG%^WGG ---)N"$O( F..o^W..^F..c -&')N
WG'^WG%^WGG --%)O"$O( W.N^W..^F..W -&')N
WGO^WGG^WG% --%)."$O( F..o^W..^F..W -&')N
WGO^WGG^FGGo -&')- F..c^W..^F..W -&')N
WG%^WGG^FGGo -&')-
P%^W-^W%^WG& -N.)N"$O( W-G^W%N^W%I^W%R NI)."$O(
P-^W-^W%^WG& e%I)O"$N( W-&^W%I^W%'^WG& GI)%"$O(
P%^W-^W%^W' GO)-"$N( W%R^W%I^W%'^WG& eR&)G"$O(
P-^W-^W%^W' e-O')'"$G( W%N^W%I^W%'^WG& -NI)."$G(
P%^W-^W%^WG eRN)%"$N( W%I^W%'^WG&^W% eNG)'"$O(
P-^W-^W%^WG '&)'"$O( W-^W%^WG&^W%' e.-)-"$O(
W-^W%^WG^WO -.')-"$O( W'^W%^WG&^W%' .-)%"$O(
WG&^W%^WG^WO eI-)."$N( WG^W%^WG&^W%' e-IN)&"$G(
W'^W%^WG^WO N-)%"$N( PO^WG-^WG%^W.& -N%)."$N(
W%^WG^WO^WN eNN)O"$N( PN^WG-^WG%^W.& eG-)%"$.(
WG^WO^WN^WI -IN)%"$O( PO^WG-^WG%^WG' G-)R"$.(
WG^WO^WN^W. e.N)-"$N( PN^WG-^WG%^WG' e-N%)&"$O(
WG^WO^WN^WR N.)-"$N( PO^WG-^WG%^WGG eRI)N"$.(
WO^WN^WR^W' eN.)-"$N( PN^WG-^WG%^WGG RR)I"$N(
WI^WN^WR^W' e-IN)&"$O( WG-^WG%^WGG^WGO -..)O"$N(
W.^WN^WR^W' .N)G"$N( W.&^WG%^WGG^WGO eIG)O"$.(
W-^W%^W'^W-& I&)R"$O( WG'^WG%^WGG^WGO O')R"$.(
WG&^W%^W'^W-& eN%)N"$O( WG%^WGG^WGO^WGN eNO)&"$.(
WG^W%^W'^W-& e-IN)O"$G( WGG^WGO^WGN^WG. e..)N"$.(
W-^W%^W'^WR e-.G)-"$G( WGG^WGO^WGN^WGR N.)%"$.(
WG&^W%^W'^WR IG)N"$O( WGG^WGO^WGN^WGI -IG)O"$O(
$%&&'()(*+,-."),+(-/,'$
$%&#:G
WG^W%^W'^WR eO')G"$O( WGO^WGN^WGR^WG' eNI)."$.(
WN^WR^W'^W-& -I')%"$O( WG.^WGN^WGR^WG' .N)-"$I(
WN^WR^W'^W% NG)I"$N( WGI^WGN^WGR^WG' e-IG)O"$.(
W%^W'^W-&^W-- e-OO)G"$G( WGN^WGR^WG'^WO& e-II)."$N(
WR^W'^W-&^W-- '&)O"$O( WGN^WGR^WG'^WG% NN)O"$.(
W%^W'^W-&^W%I G')."$O( WG-^WG%^WG'^WO& .R)'"$O(
WR^W'^W-&^W%I eRN)."$O( W.&^WG%^WG'^WO& eNG)O"$O(
W'^W-&^W--^W-% e-I')&"$G( WGG^WG%^WG'^WO& e-II)R"$G(
W%I^W-&^W--^W-% e%)'"$.( WG-^WG%^WG'^WGR e-.G)%"$O(
W-&^W--^W-%^W-G %)'"$N( W.&^WG%^WG'^WGR IO)N"$O(
W--^W-%^W-G^W%N eGG)G"$O( WGG^WG%^WG'^WGR eO')'"$N(
W--^W-%^W-G^W-O e-.I)'"$G( WGR^WG'^WO&^WO- 'G)N"$N(
W-%^W-G^W-O^W-N NO)'"$O( WG%^WG'^WO&^WO- e-G')'"$O(
W%N^W-G^W-O^W-N eI.)O"$O( WGR^WG'^WO&^WNI eRO)%"$N(
W-%^W-G^W-O^W%% e-I')&"$G( WG%^WG'^WO&^WNI O%)G"$N(
W%N^W-G^W-O^W%% O')."$O( WNI^WO&^WO-^WO% e-)R"$I(
W-%^W-G^W-O^W-. e.N)%"$O( WG'^WO&^WO-^WO% e-I')N"$O(
W%N^W-G^W-O^W-. -.G)N"$G( WO&^WO-^WO%^WOG .)I"$I(
W-N^W-O^W-.^W-I .%)&"$N( WO-^WO%^WOG^WNN eGI)'"$N(
W%%^W-O^W-.^W-I eN')R"$N( WO-^WO%^WOG^WOO e-I-)."$O(
W-G^W-O^W-.^W-I e-IO)O"$O( WO%^WOG^WOO^WO. e.-)I"$N(
W-O^W-.^W-I^W-R %O)G"$.( WNN^WOG^WOO^WO. -.R)&"$G(
W-O^W-.^W-I^W-R[ N%)&"$.( WO%^WOG^WOO^WN% e-II)I"$O(
W-R[^W-I^W-R^PG ---)'"$--( WNN^WOG^WOO^WN% N%)&"$O(
W-.^W-I^W-R^PG e-.-)R"$N( WO%^WOG^WOO^WON NI)."$.(
W-R[^W-I^W-R^W-' e.')&"$--( WNN^WOG^WOO^WON eI%)I"$N(
W-.^W-I^W-R^W-' -I)G"$N( WN%^WOO^WO.^WOI eN%)O"$N(
W-R^W-I^W-R[^PG[ e--')&"$-&( WON^WOO^WO.^WOI I&)%"$N(
W-.^W-I^W-R[^PG[ -G.)O"$.( WOG^WOO^WO.^WOI e-.I)-"$O(
W-R^W-I^W-R[^W-' .&)R"$-&( WOO^WO.^WOI^WOR N.)-"$N(
W-.^W-I^W-R[^W-' eOG)R"$.( WO.^WOI^WOR^P. -%G)I"$.(
PG^W-R^W-'^W-R[ e--G)%"$--( WO.^WOI^WOR^WO' eNO)."$.(
W-I^W-R^W-'^W-R[ .I)I"$--( P.^WOR^WO'^WN& e--)O"$I(
PG^W-R^W-'^W%& eI')G"$O( WOI^WOR^WO'^WN& -..)'"$N(
W-I^W-R^W-'^W%& -&-)."$O( P.^WOR^WO'^WN- -&N)%"$.(
PG^W-R^W-'^W%- G.)&"$O( WOI^WOR^WO'^WN- eI.)N"$.(
W-I^W-R^W-'^W%- e-OG)-"$O( P.^WOR^WO'^WN% e-G-)-"$N(
PG^W-R^W-'^W%% -.&)."$O( WOI^WOR^WO'^WN% OI)-"$N(
W-I^W-R^W-'^W%% e-R)N"$O( WO.^WOO^WN%^WNG e-IN)I"$O(
PG[^W-R[^W-'^W-R --R)&"$-&( WON^WOO^WN%^WNG .O)N"$N(
W-I^W-R[^W-'^W-R e.-)I"$-&( WOG^WOO^WN%^WNG e.&)."$O(
PG[^W-R[^W-'^W%& eG&)%"$.( WO.^WOO^WN%^WO' N&)G"$N(
W-I^W-R[^W-'^W%& -N&)&"$N( WON^WOO^WN%^WO' e.')N"$N(
PG[^W-R[^W-'^W%- I')R"$R( WOG^WOO^WN%^WO' -.N)O"$G(
W-I^W-R[^W-'^W%- e-&&)&"$I( WN&^WO'^WN%^WNG .%)N"$N(
PG[^W-R[^W-'^W%% e-G')N"$.( WOR^WO'^WN%^WNG e-I')G"$O(
W-I^W-R[^W-'^W%% O&)R"$.( WN-^WO'^WN%^WNG eN')I"$.(
W-N^W-O^W%%^W%G .')'"$O( WN&^WO'^WN%^WOO e-.O)."$O(
W-.^W-O^W%%^W%G e-I&)R"$G( WOR^WO'^WN%^WOO eO.)O"$N(
$%&&'()(*+,-."),+(-/,'$
$%&#:H
W-G^W-O^W%%^W%G eN.)'"$O( WN-^WO'^WN%^WOO IG)%"$.(
W-N^W-O^W%%^W-' eN')R"$O( WOO^WN%^WNG^WNO .O)&"$N(
W-.^W-O^W%%^W-' N')O"$O( WO'^WN%^WNG^WNO e-N')O"$O(
W-G^W-O^W%%^W-' -IG)G"$G( WN%^WNG^WNO^WNN eNN)G"$N(
W-R^W-'^W%%^W%G e-N-)N"$G( WNG^WNO^WNN^WN. eI.)'"$N(
W-R[^W-'^W%%^W%G e-II)'"$N( WNG^WNO^WNN^WOG OO)O"$N(
W%&^W-'^W%%^W%G RR)-"$N( WNG^WNO^WNN^WNI -.%)'"$O(
W%-^W-'^W%%^W%G eG-)&"$.( WO%^WOG^WNN^WN. eN.)I"$N(
W-R^W-'^W%%^W-O e%-)'"$O( WOO^WOG^WNN^WN. IN)I"$N(
W-R[^W-'^W%%^W-O eOR)%"$N( WO%^WOG^WNN^WNO e-I.)."$O(
W%&^W-'^W%%^W-O e-O%)%"$O( WOO^WOG^WNN^WNO eOO)G"$O(
W%-^W-'^W%%^W-O 'R)I"$N( WO%^WOG^WNN^WNI .G)O"$O(
W-O^W%%^W%G^W%O .%)R"$O( WOO^WOG^WNN^WNI e-.O)%"$G(
W-'^W%%^W%G^W%O e-.N)N"$G( WO-^WO&^WNI^WN' -O')&"$O(
W%%^W%G^W%O^W%N eNI)I"$O( WG'^WO&^WNI^WN' eGG)G"$N(
W%G^W%O^W%N^W%. eI%)'"$O( WO-^WO&^WNI^WNR e'O)&"$N(
W%G^W%O^W%N^W-G OR)G"$O( WG'^WO&^WNI^WNR RG)I"$O(
W%G^W%O^W%N^W%I -..)O"$G( WO-^WO&^WNI^WNN %I)I"$N(
W-%^W-G^W%N^W%O e-IR)O"$G( WG'^WO&^WNI^WNN e-NO)."$O(
W-O^W-G^W%N^W%O eON)N"$O( WN.^WNN^WNI^WO& .G)-"$N(
W-%^W-G^W%N^W%. eNR)%"$O( WNO^WNN^WNI^WO& e-II)I"$G(
W-O^W-G^W%N^W%. IO)I"$O( WOG^WNN^WNI^WO& eNI)O"$O(
W-%^W-G^W%N^W%I .-)'"$O( WN.^WNN^WNI^WN' e.&)G"$N(
W-O^W-G^W%N^W%I e-.N)%"$G( WNO^WNN^WNI^WN' NR)'"$O(
W--^W-&^W%I^W%' -N%)."$G( WOG^WNN^WNI^WN' -I')%"$G(
W'^W-&^W%I^W%' eG-)O"$O( WN.^WNN^WNI^WNR e-IR)."$O(
W--^W-&^W%I^W%R eR')."$O( WNO^WNN^WNI^WNR eN')O"$N(
W'^W-&^W%I^W%R R.)O"$O( WOG^WNN^WNI^WNR .&)'"$O(
W--^W-&^W%I^W%N G-)'"$O( WO&^WNI^WN'^W.& GI)%"$N(
W'^W-&^W%I^W%N e-N%)-"$G( WNR^WNI^WN'^W.& eI')R"$O(
W%O^W%N^W%I^W-& -I')."$G( WNN^WNI^WN'^W.& -NR)N"$G(
W%.^W%N^W%I^W-& N')R"$O( WG-^WG%^W.&^WN' e.&)%"$N(
W-G^W%N^W%I^W-& e.&)O"$G( WG'^WG%^W.&^WN' .&)%"$N(
W%O^W%N^W%I^W%' N.)O"$O( WGG^WG%^W.&^WN' e-IO)'"$O(
W%.^W%N^W%I^W%' e.G)O"$O( WNI^WN'^W.&^WG% eN%)R"$N(
W-G^W%N^W%I^W%' -I.)O"$G( W.%^W.G^W.O^W.N e-N'"$%(
W%O^W%N^W%I^W%R e.%)O"$O( W.O^W.G^W.%^W.- eIG"$%(
W%.^W%N^W%I^W%R -II)R"$G( W.G^W.O^W.N^W.. -R&"$%(
S*4)=T>2#9=24"T>=D>&)*"JKQ"RM
7^Fddd$ 7^F Fddd$ 7ddd$ 7^Fddd$
P-^F-dddPO &)RO -)I- %)NON"$O( -I-
PN^FNdddP% &)RO -)RG %).GI"$O( -.&
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R factor = 0.037; wR factor = 0.097; data-to-parameter ratio = 10.4.
In the molecule of pinnatane A, C30H48O3, isolated from the
bark of Walsura pinnata Hassk, the four cyclohexane rings
adopt chair conformations; the carboxyl and hydroxy
substituents occupy axial positions. The cyclohexene ring is
envelope-shaped. Adjacent molecules are linked by O—
H  O hydrogen bonds into a chain running along the c axis.
Related literature







a = 7.3761 (2) A˚
b = 16.3585 (4) A˚
c = 20.7032 (5) A˚
V = 2498.1 (1) A˚3
Z = 4
Mo K radiation
 = 0.08 mmÿ1
T = 100 K







2881 reflections with I > 2(I)
Rint = 0.045
Refinement
R[F 2 > 2(F 2)] = 0.037





H atoms treated by a mixture of
independent and constrained
refinement
max = 0.27 e A˚
ÿ3
min = ÿ0.17 e A˚
ÿ3
Table 1
Hydrogen-bond geometry (A˚, ).
D—H  A D—H H  A D  A D—H  A
O1—H1  O3i 0.85 (1) 1.90 (1) 2.731 (2) 167 (3)
O3—H3  O2ii 0.84 (1) 2.36 (2) 3.080 (2) 144 (2)
Symmetry codes: (i) ÿxþ 12;ÿyþ 2; zÿ
1





Data collection: APEX2 (Bruker, 2007); cell refinement: SAINT
(Bruker, 2007); data reduction: SAINT; program(s) used to solve
structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine
structure: SHELXL97 (Sheldrick, 2008); molecular graphics: X-
SEED (Barbour, 2001); software used to prepare material for
publication: publCIF (Westrip, 2009).
We thank the University of Malaya for supporting this
study.
Supplementary data and figures for this paper are available from the
IUCr electronic archives (Reference: WN2325).
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